"The Corporate Responsibility Report provides a 360-degree view of our business activities. We are applying sustainability measures in areas where we can achieve the greatest possible benefit for society and for the environment", says Tilo Köster, Speaker of the Management Board of McKesson Europe. For the first time, this year McKesson is publishing a joint Corporate Responsibility Report for all three business regions within the company (USA, Canada and Europe).
An example of McKesson's Corporate Responsibility is an initiative in the key area "Product Quality and Patient Safety". With the introduction of the European Falsified Medicines Directive, extensive measures have already been taken for example in France, to track down medicines and to eliminate falsified products in the supply chain. In the field of "Eco-Efficient Operations and Transportation", too, McKesson has achieved significant successes over the past fiscal year (1 April 2017 to 31 March 2018). Thanks to the systematic conversion of pharmacies and wholesale branches to LED lighting, 1.5 million kilowatt hours of electricity are saved worldwide every year. In addition to this, McKesson is continuously reducing its CO2 emissions in the transport sector through efficient route planning, modern fleets and training in eco-efficient driving.
McKesson's key areas within sustainability are derived from a materiality analysis, in which a total of 95 stakeholders, including employees, suppliers and customers were surveyed. The result is a list of priorities of the most important sustainability issues the company and its stakeholders expect to become increasingly important in the coming years.
The Corporate Responsibility Report is available here: CR Report FY18 (PDF 6.7 MB)
About McKesson Europe
With strong brands and about 38,000 employees, McKesson Europe is active in 13 European countries. Every day, the company serves over 2 million customers – at around 2,300 McKesson-owned pharmacies and at over 7,000 participants in the brand partnership schemes. With 118 wholesale branches in Europe, McKesson Europe supplies more than 50,000 pharmacies and hospitals every day with more than 100,000 pharmaceutical products. McKesson Corporation, San Francisco, USA, is the majority shareholder in McKesson Europe AG. McKesson Corporation, currently ranked 6th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.